Standard BioTools Net Profit Margin 2010-2025 | LAB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Standard BioTools net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Standard BioTools net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.5B
Tempus AI (TEM)	$12.7B
Doximity (DOCS)	$11.9B
Hims & Hers Health (HIMS)	$9.5B
IRhythm Technologies (IRTC)	$5.1B
Hinge Health (HNGE)	$4.4B
Inspire Medical Systems (INSP)	$2.7B
Privia Health (PRVA)	$2.6B
Heartflow (HTFL)	$2.5B
Enovis (ENOV)	$1.7B
Phreesia (PHR)	$1.7B
10x Genomics (TXG)	$1.7B
Omnicell (OMCL)	$1.5B
Schrodinger (SDGR)	$1.4B
Azenta (AZTA)	$1.4B
Clover Health Investments (CLOV)	$1.3B
Claritev (CTEV)	$1.1B
Evolent Health (EVH)	$1.1B
Fulgent Genetics (FLGT)	$660M
Zepp Health (ZEPP)	$568M
Veradigm (MDRX)	$520M
Talkspace (TALK)	$430M
Butterfly Network (BFLY)	$347M
Carlsmed (CARL)	$333M
TruBridge (TBRG)	$293M
SOPHiA GENETICS SA (SOPH)	$237M
Outset Medical (OM)	$237M
Nyxoah SA (NYXH)	$214M
Health Catalyst (HCAT)	$211M
KORU Medical Systems (KRMD)	$190M